The three-year agreement on cold chain logistics covers transportation including ocean services and inland logistics.
"We are proud to be chosen as one of Novo Nordisk´s main logistic companies. Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions. This achievement showcases the rapid transformation of A.P. Moller - Maersk as a modern end-to-end logistics company with fully controlled assets," said Vincent Clerc, Executive Vice President and CEO Ocean and Logistics. A.P. Moller - Maersk.
One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk´s ECO Delivery to reduce the carbon footprint in transportation. The initiative uses sustainable biofuel to power selected Maersk-vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals.
The global agreement will enter effect as of 1st April 2021.
Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business. We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.
About A.P. Moller - Maersk
A.P. Moller - Maersk is an integrated container logistics company working to connect and simplify its customers’ supply chains. As the global leader in shipping services, the company operates in 130 countries and employs roughly 80,000 people.
For further information, please contact:

无论您需要什么,我们都可以随时为您提供帮助
提交此表,即表示我同意通过电子邮件接收 A. P. 穆勒-马士基集团及其关联公司接收物流相关新闻和营销信息更新。我了解我可以随时通过点击退订链接,取消接收此类马士基推送信息。如需查看我们会如何处理您的个人信息,请查阅隐私公告。